Suppr超能文献

拉科酰胺在成人部分性发作患者中的耐受性:计划减量的影响及联合抗癫痫药物的作用机制

Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.

作者信息

Foldvary-Schaefer Nancy, Fong Joanna S, Morrison Shannon, Wang Lu, Bena James

机构信息

Cleveland Clinic Neurological Institute, Cleveland, OH, United States.

University of Pittsburgh Department of Neurology, Pittsburgh, PA, United States.

出版信息

Epilepsy Behav. 2016 Apr;57(Pt A):155-160. doi: 10.1016/j.yebeh.2016.02.007. Epub 2016 Mar 5.

Abstract

OBJECTIVE

We evaluated the impact of planned dose reduction and mechanism of action of concomitant AEDs on tolerability in adults with partial-onset seizures undergoing lacosamide (LCM) titration.

METHODS

Data were collected at baseline and 3-6 and 12-24 months post-LCM initiation. Subjects were categorized as having planned reduction of concomitant AEDs or not; AEDs were categorized as traditional sodium channel blockers (TSCB) or non-TSCB (NTSCB). Groups with/without planned reduction were compared on the presence and number of treatment-emergent adverse events (TEAEs) using chi-square tests or logistic regression and on time to LCM discontinuation with time-to-event methods controlling for standardized (STD) AED dose, a measure of concomitant AED load. Similar analyses were performed comparing subjects taking TSCB and NTSCB agents and used to identify relationships with ≥50% decreases in seizure frequency.

RESULTS

One hundred six adults (mean age 41.4 ± 13.4; 50% male) underwent LCM titration from June 2009-2011 with complete data. Reduction of concomitant AEDs was planned at the time of LCM initiation in 59 (55.7%) subjects. Fewer subjects with planned reduction had TEAEs (49.2% vs. 68.1%; p=0.05), and these subjects had a lower risk of TEAEs (OR 0.36; p=0.019) after adjusting for STD AED dose. The hazard ratio (95% CI) for LCM discontinuation was 0.46 (0.23, 0.94) in subjects with planned reduction of concomitant AEDs vs. others (p=0.033) and 3.29 (1.01, 10.70) in subjects taking TSCB vs. NTSCB agents (p=0.048). Among all cases, those who ever had TEAEs had significantly higher STD dose at both follow-up visits (p=0.033 and p=0.023, respectively). Seizure outcomes were not significantly different between groups at the last follow-up assessment.

SIGNIFICANCE

Planned reduction of concomitant AEDs during LCM initiation and the use of NTSCB agents only are associated with a reduced risk of TEAEs and LCM discontinuation in adults with partial-onset seizures. This study extends prior observations by considering total AED load in the assessment of tolerability and supports the benefits of early reduction of concomitant AEDs during LCM initiation.

摘要

目的

我们评估了计划剂量减少以及联合使用抗癫痫药物(AEDs)的作用机制对接受拉考沙胺(LCM)滴定的部分性发作成年患者耐受性的影响。

方法

在基线以及LCM开始治疗后的3 - 6个月和12 - 24个月收集数据。受试者被分类为是否计划减少联合使用的AEDs;AEDs被分类为传统钠通道阻滞剂(TSCB)或非TSCB(NTSCB)。使用卡方检验或逻辑回归比较有/无计划减少联合用药组的治疗中出现的不良事件(TEAE)的发生情况和数量,并使用事件时间方法比较LCM停药时间,同时控制标准化(STD)AED剂量,这是一种联合AED负荷的测量指标。对服用TSCB和NTSCB药物的受试者进行了类似分析,以确定与癫痫发作频率降低≥50%的关系。

结果

2009年6月至2011年期间,106名成年人(平均年龄41.4±13.4岁;50%为男性)接受了LCM滴定,并有完整数据。59名(55.7%)受试者在开始使用LCM时计划减少联合使用的AEDs。计划减少联合用药的受试者发生TEAE的较少(49.2%对68.1%;p = 0.05),在调整STD AED剂量后,这些受试者发生TEAE的风险较低(OR 0.36;p = 0.019)。联合使用的AEDs计划减少的受试者与其他受试者相比,LCM停药的风险比(95%CI)为0.46(0.23,0.94)(p = 0.033),服用TSCB药物的受试者与服用NTSCB药物的受试者相比为3.29(1.01,10.70)(p = 0.048)。在所有病例中,那些曾发生TEAE的患者在两次随访时的STD剂量均显著更高(分别为p = 0.033和p = 0.023)。在最后一次随访评估时,各组之间的癫痫发作结果无显著差异。

意义

在开始使用LCM时计划减少联合使用的AEDs以及仅使用NTSCB药物与部分性发作成年患者发生TEAE和LCM停药的风险降低相关。本研究通过在耐受性评估中考虑总AED负荷扩展了先前的观察结果,并支持在开始使用LCM时早期减少联合使用的AEDs的益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验